Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
Description
CONCLUSION: Our analysis of the exhaustive PMSI database showed a suboptimal implementation of BoNT-A treatment recommendations in France. BoNT-A treatment initiation and re-administration are low, particularly in patients with post-stroke spasticity
